Chiltern Capital has invested in  Surepharm, a contract development manufacturing organisation servicing the pharmaceutical market. Carter Schwartz’s, Lewis Buckley, advised on the management team hires. Surepharm provides outsourced formulation, development, manufacturing, and packaging of products for its customers in the UK and overseas. It currently specialises in producing solid dose tablets and capsules, including niche…

Read more »